Latest Information Update: 21 Oct 1997
At a glance
- Originator Research Biochemicals
- Developer Nonindustrial source; Research Biochemicals
- Class Hormones
- Mechanism of Action Serotonin uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 21 Oct 1997 No-Development-Reported for Cancer in USA (Unknown route)
- 22 Sep 1995 New profile
- 22 Sep 1995 Preclinical development for Cancer in USA (Unknown route)